Funded Tech Companies

Ajax Therapeutics

Researching who backed Ajax Therapeutics? Eli Lilly and Company, Schrodinger and Vivo Capital joined the equity holders in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Advances in molecular genetics and biology have led to the development of new classes of targeted therapies for the treatment of hematologic malignancies. However, many of these therapies, while selective for a particular drug target, often interact with other related proteins which can limit their efficacy and lead to unwanted side effects.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/13/2024

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Martin Vogelbaum

        

VP - R & D

Craig Masse

        

Company Investors

• Eli Lilly and Company
• Schrodinger
• Vivo Capital
• Boxer Capital
• Point72 Ventures
• RA Capital Management
• EcoR1 Capital Management (Scott Platshon)
• Goldman Sachs (Ming Cheah)
• OneVentures
• Memorial Sloan Kettering Cancer Center
• NYU Langone Health

Browse more funded tech companies:

Ajax Health | Ajax Vascular

Share this article

About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary